Sponsor Confidential Information Sample Clauses

Sponsor Confidential Information. If, in the performance of the Research, the Principal Investigator and members of the MIT research team designated by him/her affirmatively accept access offered by Sponsor to certain information that Sponsor considers confidential, the rights and obligations of the Parties with respect to such information are as follows:

Sponsor Confidential Information. Sponsor holds a proprietary interest in Study materials and in any written and oral information that Sponsor discloses to PPD under this Agreement. Sponsor considers all such materials and information supplied to PPD by Sponsor, or generated by PPD under this Agreement to be confidential information of Sponsor (“Sponsor Confidential Information”). As used herein, the Sponsor Confidential Information shall also include the Deliverables, Sponsor Inventions, and any other data, methods, results, conclusions, information and/or other deliverables made, conceived, reduced to practice or otherwise generated in connection with this Agreement, whether by Sponsor or PPD. PPD shall treat all Sponsor Confidential Information as the confidential and exclusive property of Sponsor, including all tangible and intangible forms of such information.

Sponsor Confidential Information. Should it be necessary for Purdue personnel to receive Sponsor’s confidential information, Sponsor agrees to state in writing at the time of delivery that such information is confidential, or if given orally, the confidential information shall (within 30 days of the oral disclosure) be reduced to writing and clearly marked as confidential. Purdue agrees to safeguard Sponsor’s confidential information to the same extent that Purdue safeguards its own confidential information. Purdue shall, upon request of Sponsor, return Sponsor’s confidential information to Sponsor at the conclusion of the Project.

Sponsor Confidential Information. (a) The parties acknowledge that as part of the scientific collaboration between Sponsor and Hospital in connection with the Program, Sponsor may find it necessary or desirable to the conduct of the Program to disclose to Hospital's Office of Research Administration, Finance, Public Affairs or General Counsel certain confidential and proprietary information and trade secrets of Sponsor. Such information may take the form of, among other things: data concerning scientific discoveries made by Sponsor; Sponsor's manufacturing strategies and processes; Sponsor's marketing plans; data from Sponsor's evaluations in animals and humans; Sponsor's budget information; Sponsor's strategy for or status of regulatory approval; or Sponsor's forecasts of sales and sales data, and other proprietary or confidential information (hereafter referred to collectively as "Sponsor Confidential Information"). (b) Notwithstanding the above, Sponsor acknowledges and agrees that none of the information described in subparagraph (a) above will be considered Sponsor Confidential Information for purposes of this Agreement, unless said information is disclosed by Sponsor in writing and is clearly marked as confidential, or, where verbally disclosed by Sponsor, is followed within thirty (30) days of such verbal disclosure by a writing from Sponsor confirming such disclosure and indicating that such disclosure is confidential. (c) Notwithstanding anything herein to the contrary and consistent with Hospital's policies, Sponsor further acknowledges and agrees that Sponsor Confidential Information shall not include data generated by Hospital or the Principal Investigator or his/her associates, coworkers or staff in connection with the Program. Sponsor and Hospital acknowledge that such data is subject to the disclosure limitation included in Section 4 of this Agreement. (d) Subject to the terms and conditions of this Agreement, Hospital hereby agrees that during the term of the Research Agreement and for a period of five (5) years thereafter, Hospital shall (i) cause Hospital staff assigned to any of the Office of Research Administration, Finance, Public Affairs or General Counsel not to publicly divulge, disseminate, publish or otherwise disclose any Sponsor Confidential Information without Sponsor's prior written consent; (ii) limit access to Sponsor Confidential Information to those members of Hospital staff in the above-mentioned Offices who have a need for such Sponsor Confidential Infor...

Sponsor Confidential Information a. Sponsor may disclose confidential information to SynteractHCR during the course of this Agreement. All information provided by or on behalf of Sponsor or data collected by SynteractHCR during the performance of the Services is deemed to be the confidential information of Sponsor and is hereinafter referred to as “Sponsor Information”. SynteractHCR will keep Sponsor Information confidential in a secure location and exercise the same degree of care as it does for its own confidential information, and at least a reasonable degree of care. SynteractHCR will not disclose Sponsor Information to any third party, and shall only disclose Sponsor Information to its employees and Subcontractors who have a need to know such Sponsor Information in order to perform the Services. SynteractHCR shall not use, and shall ensure that its permitted employees and Subcontractors shall not use, such Sponsor Information for any purpose other than the performance of Services without the prior written consent of Sponsor. b. SynteractHCR will ensure that it and its employees and Subcontractors involved in the Services will comply with terms substantively similar to the confidentiality provisions of this Agreement. c. SynteractHCR will exercise due care to prevent the unauthorized disclosure and use of Sponsor Information associated with the Services. d. This confidentiality, nondisclosure and nonuse provision will not apply to Sponsor Information that SynteractHCR can demonstrate by competent evidence: [*CONFIDENTIAL TREATMENT HAS BEEN REQUESTED AS TO CERTAIN PORTIONS OF THIS DOCUMENT. EACH SUCH PORTION, WHICH HAS BEEN OMITTED HEREIN AND REPLACED WITH AN ASTERISK ****, HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.] i. was known by SynteractHCR before initiation of the Services, as evidenced by written records; ii. was in the public domain at the initiation of the Services or subsequently became publicly available through no fault or action of SynteractHCR; or iii. was disclosed to SynteractHCR on a non-confidential basis by a third party authorized to so disclose it. e. In no event will either Party be prohibited from disclosing confidential information of the other Party to the extent required by law to be disclosed, provided that the disclosing Party provides the non-disclosing Party with written notice thereof unless prohibited by law or regulation from providing such notice, prior to disclosure, to the extent reasonably practicable, discloses only what...

Sponsor Confidential Information. PPD shall treat all information obtained from Sponsor and all Sponsor Property (as defined below) and any revisions improvements or enhancements thereto (“Sponsor Confidential Information”) as the confidential and exclusive property of Sponsor.

Sponsor Confidential Information. Should it be necessary for Auburn personnel to receive Sponsor confidential Information, Sponsor agrees to state in writing at the time of delivery that such information is confidential, or if given orally, reduced to writing, clearly marked as confidential, within 30 days of the oral disclosure. Auburn and its personnel agree to safeguard Sponsor confidential material to the same extent it safeguards its own.

Sponsor Confidential Information. PPD and any of its Affiliates or third party on its behalf shall treat all information and materials including any Project drug obtained from Sponsor or a third party on its behalf, and any Project results, data and records generated or developed during any Project, any deliverable under a Project Addendum and any Sponsor’s Property (as defined below) (“Sponsor Confidential Information”) as the confidential and exclusive property of Sponsor. In addition, any of PPD’s Affiliates or third parties performing on PPD’s behalf receiving information from Sponsor or any Sponsor’s affiliate shall be bound by the confidentiality obligations.

Sponsor Confidential Information. “Sponsor Confidential Information” means (a) any and all scientific, technical, business, regulatory, or financial information in whatever form (written, oral, electronic or visual) that is delivered or otherwise disclosed to HJF, CRO, RedHill, Sites, Site Principal Investigators, or Principal Investigator (“Recipient”), by or on behalf of HJF or RedHill or its designees (“Discloser”) for the purpose of conducting the Study, including the Protocol, the financial terms of this Agreement; (b) all approvals and correspondence with or from an IRB or other entities with oversight responsibilities for the Study, including ethics committees or data safety monitoring committees, all Study correspondence, all Study Drug accountability forms, and all CRFs (collectively, the “Study Documentation”); (c) all Study Data and (d) information that a reasonable person familiar with the Study would consider to be confidential or proprietary from the context or circumstances of disclosure; provided, however, that (i) Study Drug Sponsor and HJF are co-exclusive owners of all Study Data pursuant to Section 9.2 (Study Data and Materials) and are free to use their own Confidential Information subject to Section 7 (Publication); (ii) Protocol Principal Investigator may use and/or publish Study Data solely in accordance with this Agreement; (iii) Sites and Site Principal Investigators may use and/or publish Study Data solely in accordance with the applicable Site contract, substantially similar to those terms and conditions applicable to the Parties under this Agreement; (iv) the U.S. Government may use and/or publish Study Data and Technical Data in accordance with the OTA; and (v) a Discloser is free to use its own Sponsor Confidential Information for which it is the Discloser.

Sponsor Confidential Information. Should it be necessary for IPFW personnel to receive Sponsor Confidential Information, Sponsor agrees to state in writing at the time of delivery that such information is confidential, or if given orally, reduce to writing, clearly marked as confidential, within 30 days of the oral disclosure. IPFW and its personnel agree to safeguard Sponsor confidential material to the same extent it safeguards its own.